PFO Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about PFO clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

ElderlyIschemic StrokeEmbolic Stroke of Undetermined Source+1 more
Taichung Veterans General Hospital400 enrolled3 locationsNCT07479147
Recruiting
Not Applicable

Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study

Cryptogenic StrokePFO - Patent Foramen OvalePFO
Recross Cardio, Inc.15 enrolled5 locationsNCT07172464
Recruiting

Non-Invasive Detection of Right-to-Left Cardiac Shunts

Patent Foramen Ovale (PFO)
Scripps Health75 enrolled1 locationNCT07420400
Recruiting
Not Applicable

Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device

Hereditary Haemorrhagic TelangiectasiaPulmonary Arteriovenous MalformationPFO - Patent Foramen Ovale
St. Antonius Hospital40 enrolled1 locationNCT07414446
Recruiting

Abbott Structural Heart Device Registry

Heart DiseasesValvular Heart DiseasePFO - Patent Foramen Ovale+3 more
Abbott Medical Devices2,500 enrolled27 locationsNCT06590467
Recruiting
Not Applicable

A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine

MigrainePFO - Patent Foramen Ovale
Chinese Academy of Medical Sciences, Fuwai Hospital400 enrolled2 locationsNCT06203873
Recruiting
Not Applicable

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

StrokePFO - Patent Foramen Ovale
W.L.Gore & Associates636 enrolled44 locationsNCT03821129
Recruiting

Cerebral Microembolization Associated With PFO Closure

Atrial Septal DefectPatent Foramen Ovale (PFO)Thrombosis Cardiac
China National Center for Cardiovascular Diseases800 enrolled1 locationNCT06347276
Recruiting

Coherex-PFO-Sleep Hypoxia: A multi-center study to determine the response to closure of patent foramen ovale (PFO) with the Coherex FlatStentTM EF PFO Closure System (EF is part of the trade mark name and stands for Enhanced Foam) in patients diagnosed with PFO and significant oxygen desaturation in obstructive sleep apnea (OSA)

Significant oxygen desaturation associated with right-to-left shunts through a PFO in Obstructive Sleep Apnea(OSA) patients
Coherex Medical Inc.50 enrolled3 locationsACTRN12610000184077
Recruiting

COHEREX-EU:A Multi-Center Study to Evaluate the Safety and Efficacy of the Coherex FlatStent Patent Foramen Ovale(PFO) Closure System

Symptomatic Patent Foramen OvaleThe Coheres FlatStent Patemnt Foramen Oveale (PFO) Closure System will be implanted when closure of a Patent Foramen Ovale is clinically indicated. Each patient who receives an implant will be followed for six months after the the FlatStent is implanted. Enrollment will continue for six months or until 50 patients have been enrolled.
Coherex Medical Inc.50 enrolled2 locationsACTRN12607000623493